Featured Research

from universities, journals, and other organizations

New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing

Date:
November 27, 2007
Source:
Infectious Diseases Society of America
Summary:
In South Africa, the 2001 implementation of the World Health Organization's antituberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis. Researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years.

In South Africa, the 2001 implementation of the World Health Organization’s anti-tuberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis (XDR TB).

In a new study published in the December 1 issue of Clinical Infectious Diseases, currently available online, researchers tracked the developing drug resistance of one particular strain of Mycobacterium tuberculosis over 12 years. They found that at the time of the 2001 adoption of the DOT+ strategy for multi-drug resistant strains, the strain was already resistant to one or more of the drugs mandated by that strategy, thus allowing the strain to survive and develop resistance to additional drugs.

“The spread of a highly transmissible strain of drug-resistant tuberculosis has been facilitated by applying standard treatment regimens for susceptible and multi-drug resistant tuberculosis in the absence of drug resistance surveillance,” said one of the authors, A. Willem Sturm, MD, of the University of KwaZulu-Natal’s Nelson R. Mandela School of Medicine in South Africa. “Public health programs for the treatment and control of infectious diseases need to be supported by drug resistance surveillance programs.”

Like all bacteria, M. tuberculosis can evolve and develop resistance to the drugs that have historically killed them. The strategy that has been used to limit the development of drug-resistant TB is to treat the patient with multiple drugs so that if one drug is ineffective, then the others will ensure the elimination of the bacteria.

Drug-resistant M. tuberculosis develops when tuberculosis patients cannot or do not comply with the medication regimen. A second line of drugs has been used to treat those infected with drug-resistant TB. This second-line medication regimen was adopted in South Africa in 2001 to treat drug-resistant TB.

Unfortunately, at least one strain of M. tuberculosis in South Africa had already developed resistance to one or more of these second-line drugs by the time they were introduced. Drug susceptibility tests would have warned doctors that the standard second-line regimen was unlikely to help the patient but was likely to lead to additional drug-resistance, but these tests were not performed or were not available. Indeed, the reduced efficacy of the regimen allowed the strain to survive and, over time, develop resistances to other drugs.

The authors recorded the development of resistance to seven drugs in just over a decade in one strain of M. tuberculosis. There are very few treatment options for patients infected with XDR TB. For the most part, patients are given drugs that had been used to treat tuberculosis but which were abandoned when today’s first-line drugs became available. The older drugs were abandoned because they were less effective or more toxic.

The authors call for an increased use of drug resistance surveillance programs to help forestall the development of drug-resistance in M. tuberculosis.

Clarification:

It has come to the attention of IDSA and CID that some media coverage of the above article has suggested that the World Health Organization’s TB control program is responsible for the development of extensively drug-resistant tuberculosis (XDR TB) in South Africa. The article in question traces the development of XDR TB during the implementation of a tuberculosis control program. In their conclusion, the authors state, “It is postulated that the introduction of these programs in the absence of susceptibility testing or drug resistance surveillance has been instrumental in the development of XDR in this highly transmissible…strain.”

The World Health Organization (WHO) provides guidance to countries implementing TB control programs. Its guidance has recommended these programs include drug resistance testing if resources are available. As an advisory body, WHO does not implement TB control programs. The article in CID did not evaluate the performance of WHO, or other authorities, in the implementation of the TB control program.

It should be noted that manuscripts published in CID reflect the work of the author and not necessarily the views of the journal or IDSA.


Story Source:

The above story is based on materials provided by Infectious Diseases Society of America. Note: Materials may be edited for content and length.


Cite This Page:

Infectious Diseases Society of America. "New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing." ScienceDaily. ScienceDaily, 27 November 2007. <www.sciencedaily.com/releases/2007/10/071022120253.htm>.
Infectious Diseases Society of America. (2007, November 27). New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2007/10/071022120253.htm
Infectious Diseases Society of America. "New Strain Of Drug-resistant Tuberculosis In South Africa Traced To Lack Of Drug Susceptibility Testing." ScienceDaily. www.sciencedaily.com/releases/2007/10/071022120253.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins